Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Unconventional SNARE in The ER 1 Homolog (Use1) (Middle Region) Peptide

Use1 Reactivity: Human Host: Synthetic BP, WB, IHC
Catalog No. ABIN985958

Quick Overview for Unconventional SNARE in The ER 1 Homolog (Use1) (Middle Region) Peptide (ABIN985958)

Target

Use1 (Unconventional SNARE in The ER 1 Homolog (Use1))

Origin

Human

Source

  • 5
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Protein Region

    Middle Region

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-USE1 antibody (Catalog #: ARP34134_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    Use1 (Unconventional SNARE in The ER 1 Homolog (Use1))

    Background

    MDS032 belongs to the USE1 family and is a component of a SNARE complex which may be involved in targeting and fusion of Golgi-derived retrograde transport vesicles with the ER.

    Alias Symbols: MDS032, SLT1, p31, P31

    Protein Interaction Partner: BSCL2,BSCL2

    Protein Size: 259

    Molecular Weight

    29 kDa

    Gene ID

    55850

    NCBI Accession

    NM_018467, NP_060937

    UniProt

    Q9NZ43
You are here:
Chat with us!